Having been a French immersion student since the fourth grade, I always thought I’d had a solid command of the language.

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The global bioconjugation market is set to witness a growth rate of ~13% in the next 5 years. Increasing demand for targeted ...

Germany-headquartered technology giant Merck has set its sights on becoming the "best partner of choice" in the ...

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness, the expanding pipeline ...

In recent decades, sensor-less cars that rely on human decision-making have evolved into self-driving taxis that arrive on demand. Beate Mueller-Tiemann, PhD, CTO of the global CDMO Cytiva, points to ...

The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven ...

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, translation, and safety. This provides a robust foundation for stable and ...

G-Advanced delivers performance improvements and new capabilities as well as challenges to support these enhancements.